Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00224380 · ClinicalTrials.gov registry record · NA

Medication Adherence in Older Adults With Serious Mental Illness

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
72
Enrollment target

NCT00224380: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT00224380 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00224380, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target

Study Summary

The goal of this pilot study is to learn about how well older people with serious mental illness (including schizophrenia, schizoaffective disorder, bipolar disorder, major depression) follow prescribed medication regimens, and to evaluate a manualized intervention designed to enhance medication management skills and adherence, the Using Medications Effectively program. The following four hypotheses will be tested: 1. Medication adherence will be associated with several variables including insight, memory, medication management skill, knowledge about medications, attitudes about medications. 2. People who receive the program will have better medication adherence compared to those who do not receive the program as measured by pill counts. 3. People who receive the program will develop better medication management skills compared to those who do not receive the program.

Interventions

  • BEHAVIORAL Using Medications Effectively

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2003-07
Est. Completion 2005-02
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT00224380 record still lists

NCT00224380 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Using Medications Effectively is the first listed.

NCT00224380 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00224380 about?

NCT00224380 is a clinical study titled "Medication Adherence in Older Adults With Serious Mental Illness". The goal of this pilot study is to learn about how well older people with serious mental illness (including schizophrenia, schizoaffective disorder, bipolar disorder, major depression) follow prescribed medication regimens, and to evaluate a manualized intervention designed to enhance medication man...

What is the current status of trial NCT00224380?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2003-07. Estimated completion is 2005-02.

What interventions are being tested in trial NCT00224380?

The interventions under investigation include: Using Medications Effectively (BEHAVIORAL).

Who is sponsoring clinical trial NCT00224380?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00224380's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00224380, the US trial registry maintained by the National Library of Medicine. NCT00224380 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.